UNIVERSITE D'AIX-MARSEILLE;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);UNIVERSITE DE MONTPELLIER;CENTRE HOSPITALIER UNIVERSITAIRE DE NIMES;ASSISTANCE PUBLIQUE HOPITAUX DE MARSEI
发明人:
NATHALIE BARDIN,MARCEL BLOT-CHABAUD,SYLVIE BOUVIER,ODILE LACROIX,FRANCOISE DIGNAT-GEORGE,JEAN-CHRISTOPHE RAYMOND GRIS
申请号：
US15568097
公开号：
US20180164323A1
申请日:
2016.04.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to the field of human fertility treatment. The present invention more specifically relates to the identification of soluble CD146 (sCD146) as a biomarker which, when measured in an embryo culture medium, can be used to determine whether the embryo can be selected for implantation in the uterus of a mammal or not. The present invention thus provides a new tool and related kits to (pre)select embryo eligible for implantation. The invention also relates to methods for promoting pregnancy in a human who undergoes embryo transfer.
